SCHEMBL13680421

SCHEMBL13680421

CCCC[C@@H]1COC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13680422 1.00
SCHEMBL3852394 1.00
SCHEMBL28990851 0.94 CYP1A2 (0.46)
SCHEMBL28738568 0.92 ALDH1A1 (0.47)
SCHEMBL8045560 0.92 ALDH1A1 (0.47)
SCHEMBL28738567 0.92 ALDH1A1 (0.47)
SCHEMBL13177714 0.92 ALDH1A1 (0.47)
SCHEMBL28858956 0.92 ALDH1A1 (0.47)
SCHEMBL28212832 0.92 ALDH1A1 (0.47)
SCHEMBL28213338 0.92 ALDH1A1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582469-B2 reacting racemic 3-Butyl-oxetan-2-one with an alcohol in presence of a lipase from Candida antarctica or Burkholderia plantarii, separating the resultant product of enantiopure 3-hydroxy carboxylic acids or esters and enatiopure 3-butyl-oxetan-2-one, by distillation, extraction or a combination BASF SE (DE) 2009-09-01 US disclosed
US-7582469-B2 reacting racemic 3-Butyl-oxetan-2-one with an alcohol in presence of a lipase from Candida antarctica or Burkholderia plantarii, separating the resultant product of enantiopure 3-hydroxy carboxylic acids or esters and enatiopure 3-butyl-oxetan-2-one, by distillation, extraction or a combination BASF SE (DE) 2009-09-01 US disclosed
US-20080311633-A1 Plasmid Vectors For Transformation of Filamentous Fungi BASF AKTIENGESELLSCHAFT (DE) 2008-12-18 US disclosed
US-20080311633-A1 Plasmid Vectors For Transformation of Filamentous Fungi BASF AKTIENGESELLSCHAFT (DE) 2008-12-18 US disclosed
EP-1805314-B1 PROCESS FOR THE ENANTIOSELECTIVE OPENING OF 3-SUBSTITUTED OXETAN-2-ONES EMPLOYING LIPASES OF CANDIDA ANTARCTICA OR OF BURKHOLDERIA PLANTARRII BASF AG (DE) 2008-02-13 EP disclosed